title: Are Myeloproliferative neoplasms a risk factor for Heparin-Induced Thrombocytopenia?
authors.affiliation: Haematological Laboratory, Dijon Hospital, Dijon, France. julien.bovet@chu-dijon.fr.
authors.forename: Julien
authors.initials: J
authors.lastname: Bovet
authors.affiliation: Haematological Laboratory, Dijon Hospital, Dijon, France.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: De Maistre
authors.affiliation: Neurology Department, Dijon Hospital, Dijon, France.
authors.forename: Yannick
authors.initials: Y
authors.lastname: Bejot
authors.affiliation: Haematological Laboratory, Dijon Hospital, Dijon, France.
authors.forename: François
authors.initials: F
authors.lastname: Girodon
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000150:complications* / Q000473:pathology; D012307:Risk Factors; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D006493:Heparin
keywords: essential thrombocythaemia; heparin-induced thrombocytopenia; thrombocytopenia